{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:03:29Z","timestamp":1790269409639,"version":"4.1.0"},"reference-count":44,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Zhejiang Province Medical and Health Science and Technology Program","award":["2024KY538"],"award-info":[{"award-number":["2024KY538"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Surg Pathol"],"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To systematically analyze the immunohistochemical expression patterns of NECTIN4 and TROP2 in breast cancer, their clinicopathological correlations, and associations with PDL1 status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      NECTIN4 (H-score), TROP2 (H-score), and PDL1 (Combined Positive Score, CPS) expression were evaluated in 112 surgically resected breast carcinomas using validated immunohistochemical assays. Associations with clinicopathological variables were analyzed using Spearman's correlation, \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      tests, and Mann-Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      NECTIN4 exhibited moderate-to-high expression (H-score\u2009\u2265\u2009100) in 78% of specimens, predominantly localized to the cell membrane, and showed a significant positive correlation with HER2 positivity (\u03c1\u2009=\u20090.27,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u2009.01). TROP2 displayed near-ubiquitous moderate-to-high expression (96%) and exhibited higher expression in the triple-negative breast cancer (TNBC) subtype. Notably, there was no significant correlation between NECTIN4 or TROP2 and PDL1 co-expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides a comprehensive characterization of NECTIN4 and TROP2 expression in breast cancer, suggesting their potential as biomarkers. The observed associations with PDL1 and clinicopathological features may inform future investigations into their biological roles and clinical relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10668969261479344","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:59:46Z","timestamp":1790074786000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["NECTIN4, TROP2 and PDL1 in Breast Cancer: Immunohistochemical Profiling and Clinical Associations"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7050-372X","authenticated-orcid":false,"given":"Huamin","family":"Gu","sequence":"first","affiliation":[{"name":"Taizhou Central Hospital (Taizhou University Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Kang","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Guangzhou LBP Medicine Science &amp; Technology Co., Ltd, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liujing","family":"Huang","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Guangzhou LBP Medicine Science &amp; Technology Co., Ltd, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Guangzhou LBP Medicine Science &amp; Technology Co., Ltd, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[{"name":"Taizhou Central Hospital (Taizhou University Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Qian","sequence":"additional","affiliation":[{"name":"Taizhou Central Hospital (Taizhou University Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"He","sequence":"additional","affiliation":[{"name":"Taizhou Central Hospital (Taizhou University Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilong","family":"Fan","sequence":"additional","affiliation":[{"name":"Taizhou Central Hospital (Taizhou University Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Lu","sequence":"additional","affiliation":[{"name":"Taizhou Central Hospital (Taizhou University Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Deng","sequence":"additional","affiliation":[{"name":"Shanghai Junshi Biosciences Cp., Ltd"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Affairs Department, Guangzhou LBP Medicine Science &amp; Technology Co., Ltd, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhi","family":"Yu","sequence":"additional","affiliation":[{"name":"Taizhou Central Hospital (Taizhou University Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2024.01.006"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2021.04.021"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02108-4"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00470-8"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21705"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209124"},{"issue":"2","key":"e_1_3_3_9_2","first-page":"139","article-title":"Targeting HER2 in breast cancer: new drugs and paradigms on the horizon","volume":"2","author":"Tarantino P","year":"2021","unstructured":"Tarantino P, Morganti S, Curigliano G. Targeting HER2 in breast cancer: new drugs and paradigms on the horizon. Explor Target Antitumor Ther. 2021;2(2):139\u2013155.","journal-title":"Explor Target Antitumor Ther"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03638-2"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035807"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.6529"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8738"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa201"},{"issue":"4","key":"e_1_3_3_15_2","first-page":"791","article-title":"Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy","volume":"20","author":"Amat S","year":"2002","unstructured":"Amat S, Penault-Llorca F, Cure H, et al. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy. Int J Oncol. 2002;20(4):791\u2013796.","journal-title":"Int J Oncol"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21388"},{"issue":"7","key":"e_1_3_3_17_2","first-page":"1391","article-title":"Trop-2 and nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs\u2019 development","volume":"128","author":"Moretto R","year":"2023","unstructured":"Moretto R, Germani MM, Giordano M, et al. Trop-2 and nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs\u2019 development. Br J Cancer. 2023;128(7):1391\u20131399.","journal-title":"Br J Cancer"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000941"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000938"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2023.152226"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-73"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2017.07.019"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw678"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-025-02185-x"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/17588359251316176"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156032"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2023.10.003"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.15130"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211706"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0311185"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.06.002"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.08.016"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1313"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2014.32"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-937"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55460-9"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2017.06.007"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1369\/0022155411410430"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235936"},{"issue":"2","key":"e_1_3_3_40_2","first-page":"759","article-title":"Trop2 is a potential biomarker for the promotion of EMT in human breast cancer","volume":"40","author":"Zhao W","year":"2018","unstructured":"Zhao W, Kuai X, Zhou X, et al. Trop2 is a potential biomarker for the promotion of EMT in human breast cancer. Oncol Rep. 2018;40(2):759\u2013766.","journal-title":"Oncol Rep"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.36"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45014"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00341-6"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231183679"}],"container-title":["International Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10668969261479344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10668969261479344","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10668969261479344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:22:56Z","timestamp":1790266976000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10668969261479344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":44,"alternative-id":["10.1177\/10668969261479344"],"URL":"https:\/\/doi.org\/10.1177\/10668969261479344","relation":{},"ISSN":["1066-8969","1940-2465"],"issn-type":[{"value":"1066-8969","type":"print"},{"value":"1940-2465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"10668969261479344"}}